Andersons pediatric cardiology 1901

etal.Monitoringofacetylsalicylicacid-induced
plateletinhibitionwithimpedanceaggregometry
inchildrenwithsystemic-to-pulmonaryshunts.
CardiolYoung.2013;23(2):225–232.
39.NievesJA,UzarkK,RuddNA,etal.Interstage
homemonitoringafternewbornfirst-stage
palliationforhypoplasticleftheartsyndrome:
familyeducationstrategies.CritCareNurse.
2017;37(2):72–88.
40.WernerH,LatalB,ValsangiacomoBuechelE,
BeckI,LandoltMA.Theimpactofaninfant's
severecongenitalheartdiseaseonthefamily:a
prospectivecohortstudy.CongenitHeartDis.
2014;9(3):203–210.
41.Vrijmoet-WiersmaCM,OttenkampJ,van
RoozendaalM,GrootenhuisMA,Koopman
HM.Amulticentricstudyofdisease-related
stress,andperceivedvulnerability,inparentsof
childrenwithcongenitalcardiacdisease.Cardiol
Young.2009;19(6):608–614.
42.SarajuuriA,LonnqvistT,SchmittF,AlmqvistF,
JokinenE.Patientswithuniventricularheartin
earlychildhood:parentingstressandchild
behaviour.ActaPaediatr.2012;101(3):252–257.
43.TaylorLC,BurkeB,DonohueJE,etal.Risk
factorsforinterstagemortalityfollowingthe
norwoodprocedure:impactof


sociodemographicfactors.PediatrCardiol.
2016;37(1):68–75.

44.NationalPediatricCardiologyQuality
ImprovementCollaborative(NPC-QIC).
[Availablefrom:] />45.OsterME,EhrlichA,KingE,etal.Association
ofinterstagehomemonitoringwithmortality,
readmissions,andweightgain:amulticenter
studyfromthenationalpediatriccardiology
qualityimprovementcollaborative.Circulation.
2015;132(6):502–508.
46.SlickerJ,HehirDA,HorsleyM,etal.Nutrition
algorithmsforinfantswithhypoplasticleftheart
syndrome;birththroughthefirstinterstage
period.CongenitHeartDis.2013;8(2):89–102.
47.HehirDA,GhanayemNS.Single-ventricleinfant
homemonitoringprograms:outcomesand
impact.CurrOpinCardiol.2013;28(2):97–102.
48.ShiraliG,EricksonL,AppersonJ,etal.
Harnessingteamsandtechnologytoimprove
outcomesininfantswithsingleventricle.Circ
CardiovascQualOutcomes.2016;9(3):303–311.
49.HarahshehAS,HomLA,ClaussSB,etal.The
impactofadesignatedcardiologyteam
involvingtelemedicinehomemonitoringonthe
careofchildrenwithSingle-Ventricle
physiologyafterNorwoodpalliation.Pediatr


Cardiol.2016;37(5):899–912.
50.HillGD,RuddNA,GhanayemNS,HehirDA,
BartzPJ.Centervariabilityintimingofstage2
palliationandAssociationwithinterstage

mortality:areportfromthenationalpediatric
cardiologyqualityimprovementcollaborative.
PediatrCardiol.2016;37(8):1516–1524.
51.MezaJM,HickeyE,McCrindleB,etal.The
optimaltimingofStage-2-Palliationafterthe
Norwoodoperation.AnnThoracSurg.
2018;105(1):193–199.
52.MezaJM,HickeyEJ,BlackstoneEH,etal.The
optimaltimingofstage2palliationfor
hypoplasticleftheartsyndrome:ananalysisof
thepediatricheartnetworksingleventricle
reconstructiontrialpublicdataset.Circulation.
2017;136(18):1737–1748.
53.StoffelG,SpirigR,StiasnyB,etal.Psychosocial
impactonfamilieswithaninfantwitha
hypoplasticleftheartsyndromeduringandafter
theinterstagemonitoringperiod-aprospective
mixed-methodstudy.JClinNurs.2017;26(21–
22):3363–3370.
54.CarloWF,CarberryKE,HeinleJS,etal.
InterstageattritionbetweenbidirectionalGlenn
andFontanpalliationinchildrenwith
hypoplasticleftheartsyndrome.JThorac